Therapeutics Industry in Spain, August 2014 Market Reports from Top Publishers

You might be interested in: drug, medical equipment, cancer, more »

1-10 of 97 reports for Therapeutics

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

  • $ 3 500
  • Industry report
  • July 2014
  • by GBI Research

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market Summary GBI Research, the leading business intelligence provider, ...

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

  • $ 3 500
  • Industry report
  • June 2014
  • by GBI Research

... L, a dendritic cell-based therapeutic vaccine that acts as an add-on to the standard treatment in newly diagnosed patients, will account for much of this growth. Having demonstrated superior os improvement ...

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

  • $ 3 500
  • Industry report
  • April 2014
  • by GBI Research

... Trial failure rate analysis to assess the risk profiles of current and/or future developmental programs for pancreatic adenocarcinoma therapeutics. - Assess the potential clinical and commercial ...

Cytori Therapeutics, Inc. (CYTX) - Financial and Strategic SWOT Analysis Review

Cytori Therapeutics, Inc. (CYTX) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • April 2014
  • by Global Data

... Be missing if data is unavailable for the company cytori therapeutics, inc. (Cytx) - financial and strategic swot analysis review table of contents section 1 - about the company 5 ...

World Therapeutic Drug Monitoring (TDM) Market 2014: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts, and Strategic Profiles of Key Players

World Therapeutic Drug Monitoring (TDM) Market 2014: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts, and Strategic Profiles of Key Players

  • $ 5 500
  • Industry report
  • January 2014
  • by Venture Planning Group

... Systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others."World therapeutic drug monitoring (tdm) market 2014" is a unique worldwide market ...

Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market - (Pipeline Forecast & Market Forecast in G8 Countries) (2011 - 2020)

Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market - (Pipeline Forecast & Market Forecast in G8 Countries) (2011 - 2020)

  • $ 4 650
  • Industry report
  • December 2013
  • by MarketsandMarkets

... To the growth of the market, the cost of the therapies is majorly restraining the acute lymphocytic/lymphoblastic leukemia therapeutics market. In addition, patent expirations of some of the existing drugs ...

2014 Opportunities in the Global Therapeutic Drug Monitoring (TDM) Market

2014 Opportunities in the Global Therapeutic Drug Monitoring (TDM) Market

  • $ 5 500
  • Industry report
  • December 2013
  • by Venture Planning Group

... Opportunties in the global therapeutic drug monitoring (tdm) market" is a unique worldwide market and technology assessment designed to help current suppliers and potential market entrants ...

2014 Opportunities in the European Therapeutic Drug Monitoring (TDM) Market

2014 Opportunities in the European Therapeutic Drug Monitoring (TDM) Market

  • $ 4 200
  • Industry report
  • December 2013
  • by Venture Planning Group

... Of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others."2014 Analysis of the european therapeutic drug monitoring ...

2014 Opportunties in the Spanish Therapeutic Drug Monitoring (TDM) Market

2014 Opportunties in the Spanish Therapeutic Drug Monitoring (TDM) Market

  • $ 1 500
  • Industry report
  • December 2013
  • by Venture Planning Group

... Of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others."2014 Opportunities in the spanish therapeutic drug monitoring ...

Alzheimer's Disease Therapeutics Market to 2019 - Early Stage Innovation Points to Disease Modifying Therapies and Market Transformation

Alzheimer's Disease Therapeutics Market to 2019 - Early Stage Innovation Points to Disease Modifying Therapies and Market Transformation

  • $ 3 500
  • Industry report
  • October 2013
  • by GBI Research

... Of the highest drug attrition rates across the industry, a number of innovative and potentially disease-modifying therapeutics are likely to enter the market and translate recent insights into the etiology of ad ...

About 100 reports for Therapeutics

Download Unlimited Documents from Trusted Public Sources

Almirall - Annual Report, 2012

  • Annual Report 2012
  • January 2012
    84 pages
  • Spain  

    Europe  

View report >

2 Companies for Therapeutics

Read our Company Profiles

Abbott Laboratories

United States

Novartis Inc.

Switzerland

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.